“…Current clinical standards rely on functional testing, such as American Spinal Injury Association scoring for characterizing injury, but are often unreliable for predicting long‐term functional outcomes due to changes in score over time within some patients . Clinical magnetic resonance imaging (MRI), such as T 2 ‐weighted imaging, has aided SCI assessment, but similarly does not reliably predict long‐term functional outcomes due to the lack of specificity to axonal damage, the strongest pathological correlate of long‐term functional outcome following SCI . Thus, techniques such as diffusion‐weighted imaging (DWI), and diffusion tensor imaging (DTI) in particular, have garnered considerable interest as noninvasive biomarkers of SCI due to their sensitivity to microscopic axonal damage …”